|
|
| SPEAKER |
| Dr. Eric Daniels |
| Director |
|
Cytori Therapeutics
|
|
|
MEETING
|
|
March 2009 |
|
| BIOGRAPHY |
Eric Daniels joined Cytori Therapeutics in August 2002. His previous roles have included management of extramural research in the area of cardiovascular disease and Senior Director, Business Development, leading Cytori's efforts in corporate partnership. He currently serves as Managing Director of Cytori's European business. Dr. Daniels previously served as a general surgery resident at the University of California, Los Angeles, where he received his medical degree from the UCLA School of Medicine and his MBA from the UCLA Anderson School of Management. He received his undergraduate degree in Molecular Biology from the University of California, Berkeley.
|
| TALK |
|
Adipose-derived regenerative cells: Current clinical applications
|
| DESCRIPTION |
|
Cytori Therapeutics, Inc. (San Diego, CA, USA) is a global life sciences company commercialising cutting edge medical technologies, which enable physicians to practise regenerative medicine. The company?s main product is the Celution System. This device processes a patient?s own stem and regenerative cells at the bedside in real time so their cells may be redelivered during the same surgical procedure. Cytori is currently selling its Celution System into the cosmetic and reconstructive surgery market in Europe and Asia. In addition, the company is offering the Celution System to hospitals in Europe and Asia to perform cell-based translational research, and selling stem and regenerative cell banking equipment globally to allow hospitals and tissue banks to cryopreserve patients? own cells for future use. Because regenerative medicine touches nearly every medical discipline, Cytori?s product pipeline spans cardiovascular disease, renal failure, orthopaedic damage, gastrointestinal disorders, and pelvic health conditions, among others.
|
|
